Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

182
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
182
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

69
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
69
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Management of Insomnia01:19

Management of Insomnia

259
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
259
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

815
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
815

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Telomeres, REM sleep, and RBD: A link to neurodegeneration?

Parkinsonism & related disorders·2025
Same author

Possible REM behavior disorder following use of passionflower.

Sleep medicine·2025
Same author

Periodic limb movements in REM sleep: A periodically concerning phenomenon.

Sleep medicine·2025
Same author

Secondary RBD: Not just neurodegeneration.

Sleep medicine reviews·2024
Same author

Trauma-Associated Sleep Disorder.

Sleep medicine clinics·2024
Same author

Neurologic and psychiatric features of impending neurodegeneration in iRBD.

Clinical parkinsonism & related disorders·2023
Same journal

Response to "Insomnia subtype heterogeneity in comorbid insomnia and sleep apnea: a missing piece in mortality risk assessment".

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same journal

Veteran status as an underappreciated confound in narcolepsy mortality.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same journal

Selected abstracts from Sleep Medicine Disruptors 2025, a meeting of the American Academy of Sleep Medicine (AASM).

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same journal

Correction: Positive airway pressure-associated epiglottis-related obstruction in adult men with obstructive sleep apnea.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same journal

Efficacy of imagery rehearsal therapy in the treatment of traumatic nightmares in youth with complex post-traumatic stress disorder.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same journal

The association between slow wave activity and memory improvement following cognitive-behavioral therapy for insomnia in older adults: A secondary analysis of a randomized clinical trial​.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K

Headache improves with armodafinil.

Daniel A Barone1

  • 1Weill Cornell Center for Sleep Medicine, New York, New York.

Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|November 3, 2023
PubMed
Summary
This summary is machine-generated.

This case report details a narcolepsy and cataplexy patient whose headaches improved with armodafinil treatment. This suggests armodafinil may reduce headache frequency and severity, contrary to initial expectations.

Keywords:
armodafinilheadachenarcolepsysleepiness

More Related Videos

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

8.0K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

3.8K

Related Experiment Videos

Last Updated: Jul 11, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.3K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

8.0K
Investigating Migraine-Like Behavior Using Light Aversion in Mice
05:23

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

3.8K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Pharmacology

Background:

  • Narcolepsy and cataplexy are chronic neurological disorders affecting sleep-wake cycles.
  • Armodafinil is a wakefulness-promoting agent often prescribed for these conditions.
  • Headaches are a known potential side effect of armodafinil therapy.

Observation:

  • A patient diagnosed with narcolepsy and cataplexy experienced headache improvement during armodafinil treatment.
  • This improvement occurred despite armodafinil's potential to cause headaches.

Findings:

  • Armodafinil treatment was associated with a reduction in headache frequency and severity in this patient.
  • Potential mechanisms include reduced caffeine dependence and improved sleep-wake regulation.

Implications:

  • This case suggests a potential therapeutic benefit of armodafinil in managing headaches in patients with narcolepsy and cataplexy.
  • Further research is warranted to explore this unexpected finding and its underlying mechanisms.